{"id":858,"date":"2026-05-25T03:49:50","date_gmt":"2026-05-25T03:49:50","guid":{"rendered":"https:\/\/wuhantopmiraclepeptides.com\/?post_type=product&p=858"},"modified":"2026-08-12T08:43:32","modified_gmt":"2026-08-12T08:43:32","slug":"cartalax-20mg","status":"publish","type":"product","link":"https:\/\/wuhantopmiraclepeptides.com\/index.php\/product\/cartalax-20mg\/","title":{"rendered":"Cartalax (20mg)"},"content":{"rendered":"

Cartalax (20mg) Research Peptide: An AED Tripeptide for Cartilage, Joint & Extracellular Matrix Studies<\/span><\/h1>\n

If your research investigates cartilage biology, joint health, or the molecular mechanisms of connective tissue repair,\u00a0<\/span>Cartalax (20mg) research peptide<\/span><\/strong>\u00a0\u2014 also known as the AED tripeptide (Ala-Glu-Asp) or T-31 \u2014 offers a precisely defined synthetic tool with a growing body of scientific literature<\/span>. Belonging to the Khavinson family of peptide bioregulators, Cartalax is a short-chain synthetic peptide derived from a natural protein fragment found in healthy cartilage<\/span>. <\/span><\/p>\n

It is specifically designed to target biological pathways involved in cellular aging, inflammation, and tissue repair<\/span>. Cartalax has been shown to upregulate genes involved in cartilage matrix synthesis, support collagen and proteoglycan production, and downregulate genes associated with cartilage degradation<\/span>. This makes\u00a0<\/span>Cartalax (20mg) research peptide<\/span><\/strong>\u00a0a valuable tool for laboratories investigating osteoarthritis, connective tissue biology, extracellular matrix (ECM) dynamics, and the fundamental processes of cellular aging.<\/span><\/p>\n

At\u00a0<\/span>Wuhan Top Miracle Peptides<\/span><\/strong>, we supply high\u2011purity\u00a0<\/span>Cartalax (20mg) research peptide<\/span><\/strong>\u00a0to research institutions and wholesale buyers across the\u00a0<\/span>United Kingdom, France, Germany, Spain, Sweden, Italy, and the USA<\/span><\/strong>. Every batch is lyophilised, HPLC\u2011verified to \u226598% purity, and accompanied by a Certificate of Analysis (COA), ensuring your investigations into cartilage repair, joint health, and connective tissue biology begin with uncompromising quality.<\/span><\/p>\n

What Is Cartalax and How Does It Work?<\/span><\/h2>\n

To fully appreciate the research potential of\u00a0<\/span>Cartalax (20mg) research peptide<\/span><\/strong>, it is essential to understand its biochemical identity, its role as a tissue\u2011specific bioregulator, and the mechanisms by which it exerts its effects.<\/span><\/p>\n

The AED Tripeptide: A Structural Mimic of Type XI Collagen<\/span><\/h3>\n

Cartalax is a synthetic tripeptide consisting of three amino acids: alanine, glutamic acid, and aspartic acid \u2014 the sequence\u00a0<\/span>Ala\u2011Glu\u2011Asp (AED)<\/span><\/strong>. Its molecular formula is\u00a0<\/span>C\u2081\u2082H\u2081\u2089N\u2083O\u2088<\/span><\/strong>, with a molecular weight of approximately\u00a0<\/span>333.29 g\/mol<\/span><\/strong>.<\/span><\/p>\n

The peptide’s sequence is derived from the\u00a0<\/span>alpha\u20111 chain of type XI collagen<\/span><\/strong>, a minor fibrillar collagen that plays an essential role in maintaining cartilage integrity<\/span>. Type XI collagen is involved in organising the fibrillar structure of type II collagen, the primary collagen type found in cartilage<\/span>. By mirroring a segment of this protein, Cartalax is hypothesised to interact with collagenous matrices, potentially influencing tissue resilience and repair mechanisms<\/span>.<\/span><\/p>\n

Mechanism of Action: Multi\u2011Target Bioregulation<\/span><\/h3>\n

The biological activity of\u00a0<\/span>Cartalax (20mg) research peptide<\/span><\/strong>\u00a0is mediated through several intersecting mechanisms:<\/span><\/p>\n

Cartilage Synthesis and ECM Protection<\/span><\/strong><\/p>\n

Cartalax demonstrates an exceptional capacity to enhance tissue anabolic metabolism. It upregulates chondrocyte functional activity, rapidly increasing the synthesis and subsequent secretion of various extracellular matrix components<\/span>.\u00a0<\/span>In vitro<\/span><\/em>\u00a0studies have confirmed that treated chondrocytes or stem cells show significantly elevated gene expression levels of\u00a0<\/span>type II collagen and aggrecan<\/span><\/strong>, with corresponding increases in the actual production of said proteins<\/span>. Additionally, Cartalax inhibits the synthesis of\u00a0<\/span>MMP\u20119<\/span><\/strong>, an enzyme involved in ECM remodelling whose increased activity is associated with aging in fibroblasts<\/span>. It suppresses pro\u2011inflammatory cytokine\u2011induced MMPs and ADAMTS, mitigating the direct erosion and degradation of type II collagen and proteoglycans<\/span>.<\/span><\/p>\n

Fibroblast Proliferation and Anti\u2011Apoptotic Effects<\/span><\/strong><\/p>\n

Cartalax may contribute to the proliferation of fibroblasts, as suggested by its potential enhancement of\u00a0<\/span>Ki\u201167<\/span><\/strong>\u00a0expression, a well\u2011known marker associated with cell proliferation<\/span>. It has also been shown to suppress\u00a0<\/span>caspase\u20113<\/span><\/strong>\u00a0activity, indicating its potential to inhibit apoptosis (programmed cell death), thereby potentially contributing to an extended cellular lifespan<\/span>. The peptide \u201creduced the level of apoptosis in young and aged cultures\u201d<\/span>. It also increases the expression of\u00a0<\/span>CD98hc<\/span><\/strong>, which is implicated in the regeneration and aging processes of cells<\/span>.<\/span><\/p>\n

Senescence Marker Reduction and SIRT6 Upregulation<\/span><\/strong><\/p>\n

Research involving renal epithelial cell cultures has suggested a reduction in the expression of senescence\u2011associated proteins such as\u00a0<\/span>p16, p21, and p53<\/span><\/strong>\u00a0upon exposure to Cartalax<\/span>. Additionally, there are observations of increased expression of\u00a0<\/span>SIRT6<\/span><\/strong>, a sirtuin linked to longevity and genomic stability<\/span>. This upregulation may imply a role for Cartalax in enhancing cellular repair mechanisms and resilience to stress<\/span>.<\/span><\/p>\n

Anti\u2011Inflammatory and Immunomodulatory Effects<\/span><\/strong><\/p>\n

Cartalax actively suppresses, or at least reduces,\u00a0<\/span>NF\u2011\u03baB<\/span><\/strong>\u00a0expression \u2014 a key signal for activating numerous inflammatory factors<\/span>. This effectively alleviates the pain, swelling, and stiffness associated with inflammation<\/span>.<\/span><\/p>\n

Key Research Applications for Cartalax (20mg)<\/span><\/h2>\n

Cartalax (20mg) research peptide<\/span><\/strong>\u00a0is a versatile tool with applications spanning several domains of biomedical research.<\/span><\/p>\n

1. Cartilage & Osteoarthritis Research<\/span><\/h3>\n

As a peptide that upregulates genes involved in cartilage matrix synthesis and downregulates genes associated with cartilage degradation, Cartalax is a valuable tool for studying osteoarthritis and cartilage biology<\/span>. Research applications include:<\/span><\/p>\n